Scoopfeeds — Intelligent news, curated.
Can AstraZeneca PLC (AZN) Grow Its Rare Disease Portfolio Through Ultomiris Expansion?
business

Can AstraZeneca PLC (AZN) Grow Its Rare Disease Portfolio Through Ultomiris Expansion?

Yahoo Finance · Jun 24, 2026, 1:27 PM · Also reported by 1 other source

Can AstraZeneca PLC (AZN) Grow Its Rare Disease Portfolio Through Ultomiris Expansion?

Read full story on Yahoo Finance → More top stories

Also covered by

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop